# Gain Therapeutics, Inc. (GANX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GANX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -10.28M | $ -9.41M | $ 609.9K | $ 11.29M |
| 2025 | $ 0 | $ -20.64M | $ -18.91M | $ 732.1K | $ 18.56M |
| 2024 | $ 0 | $ -21.45M | $ -19.86M | $ 653.0K | $ 7.34M |
| 2023 | $ 59.7K | $ -24.08M | $ -20.42M | $ 1.03M | $ 12.58M |
| 2022 | $ 156.5K | $ -19.65M | $ -16.55M | $ 1.27M | $ 18.88M |
| 2021 | $ 196.1K | $ -16.51M | $ -14.81M | $ 1.61M | $ 34.82M |
| 2020 | $ 36.8K | $ -4.56M | $ -4.15M | $ 1.26M | $ 6.20M |
| 2019 | $ 40.0K | $ -3.04M | $ -2.27M | $ 201.0K | $ -449.9K |
| 2018 | $ 20.4K | $ -1.10M | $ -745.4K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.05 |
| Liabilities / Eq | 0.37 |
| Current Ratio | 4.36 |

## Other views

- [Metrics](https://sponda.capital/en/GANX.md)
- [Charts](https://sponda.capital/en/GANX/charts.md)
- [Compare](https://sponda.capital/en/GANX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.